VA North Texas Healthcare System

Dallas, Texas 75243

4 studies enrolling now · 48 studies all time

What they study most

Acute Coronary Syndrome, Amyotrophic Lateral Sclerosis (ALS), Aortocoronary Saphenous Vein Bypass Graft Atherosclerosis, Arteriosclerosis, Ascites Hepatic, Atherosclerosis, Atherosclerosis of Native Arteries of the Extremities, Unspecified, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Awake Fiberoptic Intubation, Cancer Recurrence, Cardiovascular Diseases

Studies at this site

• Integrated Health Care for PTSD — Recruiting now
• Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries — Recruiting now
• Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics — Recruiting now
• Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial — Recruiting now
• A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy — Running, not enrolling
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Veterans Coordinated Community Care (3C) Study — Completed
• Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA) — Completed
• A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD — Running, not enrolling
• A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma — Completed
• Tele-Collaborative Outreach to Rural Patients With Chronic Pain — Running, not enrolling
• Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer — Running, not enrolling
• Mixed Reality Based System to Manage Phantom Pain Phantom Pain for Patients With Lower Limb Amputation — Completed
• Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUs — Stopped early
• ORACLE-NIRS: Lipid cORe Plaque Association With CLinical Events: a Near-InfraRed Spectroscopy Study — Withdrawn before enrolling
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) — Completed
• Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis — Completed
• Mobile Health Strategies for Veterans — Status unconfirmed
• Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities — Completed
• The LIVMOR Data Collection Study for the Development and Validation of L-1000AF System — Completed
• PLATINUM Diversity — Completed
• Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D — Status unconfirmed
• Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient — Completed
• PROMUS Element Plus US Post-Approval Study — Completed
• Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory — Completed
• Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial) — Status unconfirmed
• Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD — Status unconfirmed
• Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial — Completed
• Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury — Completed
• Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis — Completed
• SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension — Completed
• SuperNOVA Clinical Stenting Trial — Completed
• AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN — Completed
• Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery — Stopped early
• Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 — Completed
• Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT) — Stopped early
• A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation — Completed
• EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries — Completed
• Effect of a Real Time Radiation Monitoring Device on Radiation Exposure During Cardiac Catheterization — Completed
• Cardiac CAtheterization for Bypass Graft Patency Rate Optimization: the CABG-PRO Randomized-controlled Pilot Study — Status unconfirmed
• Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed — Completed
• Evaluation of Protein in the Urine in Patients Receiving Bevacizumab — Completed
• Study of the Xience V Everolimus-eluting Stent in Saphenous Vein Graft Lesions — Completed
• The SOS (Stenting Of Saphenous Vein Grafts) Trial — Completed
• Use of Optical Coherence Tomography to Determine the Optimal Management of Patients With Drug-eluting Stents Who Need Non-cardiac Surgery — Stopped early
• Minimization of Surgical Site Infections for Pts Undergoing Colorectal Surgery — Completed
• Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors — Stopped early